3rd Quarter - Report

VENABLE LLP for ENDO PHARMACEUTICALS INC

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Life Sciences Jobs and Investment Act; Issues relating to incentives for life sciences research

LobbyistCovered position, as disclosed
WILLIAM R NORDWIND —
ROBERT L SMITH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Copyright/Patent/Trademark CPT

Oversight of implementation of the America Invents Act; Issues relating to patent settlements; Legislation relating to abusive patent litigation

LobbyistCovered position, as disclosed
WILLIAM R NORDWIND —
ROBERT L SMITH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Issues related to bioequivalence and related administrative procedures; issues related to prescription drug abuse; issues related to the labeling of generic drugs; issues related to tamper resistant formulation of pharmaceutical drugs. The Life Sciences Jobs and Investment Act; Issues relating to Medicare Part D rebates; H.R. 486 - Stop Tampering of Prescription Pills Act of 2013; H.R. 1919 - Safeguarding Americas Pharmaceuticals Act of 2013

LobbyistCovered position, as disclosed
WILLIAM R NORDWIND —
ROBERT L SMITH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1919 (113th), H.R. 486 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.